All updates
All updates
today 42监管与产业动态评分1717 监管与产业动态评分77 Merck's holistic HIV health hive buzzes with the help of actress Debbie Allen - Fierce Pharma
监管与产业动态评分66 Signal or noise? > Cas9 mRNA in Vitro Transcribed Market To 2035: Growth Driven by Gene Editing Scale-Up - News and Statistics - IndexBox >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #pharma #biotech #pharmaceutical #healthcare
文献与产业新闻精选评分3535 STAT+: Licensing deals on generic versions of Roche flu drug aimed at preparing for pandemic
文献与产业新闻评分1515 More IPO hopefuls aim to echo ADARx’s first-day pop: Public Equity Report
文献与产业新闻评分2727 How reverse merger-plus-PIPE deals came to rival the IPO path to market
文献与产业新闻评分2020 PIPEs power new wave of reverse mergers
文献与产业新闻评分99 STAT+: Up and down the ladder: The latest comings and goings
BioSpace评分2323 Nektar prevails in legal battle with Lilly over broken rezpeg partnership
BioSpace评分3030 ADARx raises $446M in biotech’s third largest IPO of 2026, City files to go public
BioSpace精选评分3737 Genentech makes $1.5B+ deal with AI heavyweight Earendil for cancer bispecifics
监管与产业动态精选评分3535 Signal or noise? > Enveda Raises $311 Million From Leading AI and Biotech Investors to Bring Pharma Into the 21st Century - Business Wire >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #pharma #competitivemarketing #biotech
文献与产业新闻评分1515 Network Bio: Building disease-specific AI models with biobank data
文献与产业新闻评分2525 Enveda’s latest megaround puts $311M behind AI push: Venture Report
文献与产业新闻评分55 Glaukos courts NBA champion Stephen Curry for new keratoconus awareness campaign
文献与产业新闻评分2020 Otsuka JV recalls one lot of sodium chloride over labeling issue
文献与产业新闻精选评分4242 Roche pens backloaded $2B deal with Atavistik to discover allosteric CVRM drugs
文献与产业新闻评分2020 Adagio Medical kicks off strategic review, trims more than half its staff
文献与产业新闻评分1010 Biogen springs social media kidney health campaign with Olympic gymnast Suni Lee
文献与产业新闻精选评分4242 Lilly puts up $100M, plus billions on the backend, to form 5-target deal with China's InnoCare
文献与产业新闻评分1212 Amicus vet Campbell to succeed Dube as Travere CEO
文献与产业新闻评分2828 STAT+: Flagship gets a Pentagon contract
文献与产业新闻评分1515 Novo CEO sees advantages in souping up NYSE listing: report
文献与产业新闻评分1919 Cellares pens 2nd automation test with Asia-based cell therapy partner in 2 weeks
文献与产业新闻精选评分3535 Trump's Department of War bets $47M on Flagship biotechs to develop countermeasures
文献与产业新闻评分3535 Enveda reaps $311M series E to feed ambition to become a ‘household name’
文献与产业新闻精选评分3838 Boehringer adds $250M to value of Variant pact by expanding into cardiovascular disease
文献与产业新闻评分99 STAT+: A private equity-owned hospital chain is becoming a nonprofit. Is it just a bailout for investors?
文献与产业新闻评分1818 STAT+: Drugmakers, biotech VCs show ‘reinvigorated’ interest in osteoporosis treatments
文献与产业新闻评分88 AstraZeneca recommits to youth health to dial funding past $100M
文献与产业新闻评分2222 ShennonBio: Mining rare T cells for solid tumor therapies
文献与产业新闻评分1212 Bristol Myers cuts another 265 jobs tied to New Jersey headquarters
文献与产业新闻评分1515 GSK aiming to ‘balance West and East’ after Hansoh deal success showed China’s potential
文献与产业新闻评分3636 Novartis secures new radioligand in $900M deal as competition strengthens
文献与产业新闻评分3434 Lexeo takes up the Mantle in $8M acquisition for Friedreich ataxia assets
文献与产业新闻评分1919 Travere CEO Eric Dube to step down after transforming the rare disease biotech
文献与产业新闻评分2323 Siemens Healthineers and Novo team up on fatty liver disease awareness, testing
文献与产业新闻评分2929 Par Health recalls IV sedative in US, flagging presence of cellulose, stopper material
文献与产业新闻评分2525 Anaconda Biomed snares $56M in funding for endovascular tech
文献与产业新闻精选评分4444 Iambic maintains momentum from string of Big Pharma partnerships by aiming for IPO